Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
Rosiglitazone
100%
Hyperinsulinemia
100%
Arterial Elasticity
100%
Insulin Receptor
60%
Receptor Sensitivity
60%
Insulin
40%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
40%
Small Artery Elasticity
40%
Artery Elasticity
40%
Large Arteries
40%
Hemoglobin A1c (HbA1c)
20%
Weight Gain
20%
Heart Rate
20%
Systolic Blood Pressure
20%
Diastolic Blood Pressure
20%
Hypertensive
20%
Cardiovascular Risk
20%
Plasma Insulin
20%
Proteinuria
20%
Lipid Profile
20%
Microalbuminuria
20%
Tissue Injury
20%
C-peptide
20%
24-hour Urine Collection
20%
Systemic Vascular Resistance
20%
Vascular Elasticity
20%
Vascular Compliance
20%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Hyperinsulinemia
100%
Patient with Type 2 Diabetes
100%
Rosiglitazone
100%
Insulin Receptor
60%
Receptor Sensitivity
60%
Cardiovascular Risk
20%
Systolic Blood Pressure
20%
Diastolic Blood Pressure
20%
Proteinuria
20%
Tissue Injury
20%
Microalbuminuria
20%
C-Peptide
20%
Systemic Vascular Resistance
20%
Blood Vessel Compliance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rosiglitazone
100%
Hyperinsulinemia
100%
Non Insulin Dependent Diabetes Mellitus
100%
Insulin Receptor
60%
Depressed Blood Pressure
40%
Cardiovascular Risk
20%
Microalbuminuria
20%
Proteinuria
20%
Tissue Injury
20%
C Peptide
20%